MPS Ltd reports record EBITDA of ₹236 crore in FY26, skips dividend

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • EBITDA reached ₹236 crore with a 30.7% margin in FY26
  • PAT grew 16.3%, lifting EPS to a record ₹102.11
  • Final dividend skipped to fund Unbound Medicine acquisition
  • Research and Education businesses grew 17% and 29% respectively
  • Shareholders approved re-appointment of directors and auditors
powered bylight_fuzz_icon
50092543

*this image is generated using AI for illustrative purposes only.

MPS Limited delivered its most profitable year on record in FY26, with EBITDA reaching approximately ₹236 crore and a margin of 30.7%. The company’s Profit After Tax (PAT) grew by 16.3%, driving earnings per share to a record ₹102.11.

The 56th Annual General Meeting was held on September 4, 2026, via Video Conferencing. Chairman and CEO Rahul Arora highlighted that the Research business grew by approximately 17% while the Education business expanded by nearly 29%. Return on Capital Employed stood at 38.2%.

Strategic Acquisitions And Capital Allocation

The Board did not recommend a final dividend for FY26. Capital was deployed towards the acquisition of Unbound Medicine and other opportunities under evaluation. This marks a shift from the preceding eight years, during which the company returned more than ₹650 crore to shareholders.

What the Numbers Show

The decision to forgo a dividend despite record profitability underscores a strategic pivot towards organic growth via M&A. With EBITDA margins holding steady at 30.7% while PAT grew 16.3%, the operational efficiency remains robust, allowing the firm to fund acquisitions internally without diluting equity or increasing leverage significantly.

Governance And Resolutions

Shareholders approved five resolutions during the meeting. Ordinary business included adopting the audited standalone and consolidated financial statements for the year ended March 31, 2026.

Key governance appointments included:

  • Re-appointment of Ms. Jayantika Dave as Non-Independent Non-Executive Director.
  • Re-appointment of M/s. Walker Chandiok & Co LLP as Statutory Auditors for five years.
  • Appointment of Mr. Atul Vohra as Non-Independent Non-Executive Director.
  • Re-appointment of Mr. Karthik Bhat Khandige as Independent Non-Executive Director.

The Statutory Auditors’ Report and Secretarial Auditors’ Report contained no qualifications or adverse observations. The meeting concluded with e-voting results to be declared within two working days.

Historical Stock Returns for MPS

1 Day5 Days1 Month6 Months1 Year5 Years
+1.46%-0.05%-4.03%+81.90%+18.42%+276.99%

How will the acquisition of Unbound Medicine specifically integrate with MPS's existing Research business to drive the targeted 17% growth rate?

What is the expected timeline for MPS to resume dividend payouts, and what financial metrics will trigger a return to shareholder distributions?

Given the 29% expansion in the Education business, what new product lines or market segments are driving this outperformance compared to the Research segment?

MPS Ltd receives unsolicited CRISIL ESG 64 (Strong) rating

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • MPS Limited received an unsolicited CRISIL ESG 64 (Strong) rating
  • Assessment based on FY26 disclosures and public domain data
  • Company did not engage CRISIL ESG for the evaluation
  • Disclosure made under SEBI LODR Regulation 30
powered bylight_fuzz_icon
50082432

*this image is generated using AI for illustrative purposes only.

MPS Limited received an unsolicited ESG rating of CRISIL ESG 64 (Strong) from CRISIL ESG Ratings & Analytics Limited on September 4, 2026. The assessment reflects the company’s environmental, social, and governance performance based on publicly available information.

The rating was assigned independently by CRISIL ESG, a SEBI-registered ESG Rating Provider. MPS Limited did not engage the agency for this evaluation. The assessment relies on disclosures made by the company for the financial year ended March 31, 2026, alongside other public data.

Regulatory Disclosure

The company issued the intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events to stock exchanges.

Rating Details

Parameter Detail
Rating Agency CRISIL ESG Ratings & Analytics Limited
Rating Assigned CRISIL ESG 64 (Strong)
Assessment Basis FY26 disclosures and public data
Engagement Status Unsolicited (No engagement)

Piyush Jain, Company Secretary and Compliance Officer of MPS Limited, signed the disclosure. The notification was submitted to both the National Stock Exchange of India Limited and BSE Limited.

Historical Stock Returns for MPS

1 Day5 Days1 Month6 Months1 Year5 Years
+1.46%-0.05%-4.03%+81.90%+18.42%+276.99%

How might this 'Strong' ESG rating influence MPS Limited's cost of capital or access to green financing instruments in the near future?

Given the unsolicited nature of the assessment, will MPS Limited consider engaging CRISIL or other agencies for a solicited, in-depth ESG audit to validate these findings?

What specific operational changes or capital expenditures is MPS planning to implement to address potential gaps identified in the FY26 disclosures and aim for a higher rating tier?

More News on MPS

1 Year Returns:+18.42%